This study looks at two different interventions used for the treatment of insomnia in survivors of breast, colon, lung, prostate and gynecologic cancer.
The purpose of this study is to evaluate two validated interventions for the treatment of insomnia in cancer survivors of breast, colon, lung and prostate cancer. Moreover, it will provide an opportunity to assess the efficacy of both of these interventions in a group setting in patients of varied ethnic backgrounds including African-Americans, Latinos and Caucasians. The results of this study will help clinicians provide future interventions specific to cancer type and ethnicity in order to better serve the needs of our cancer survivors and improve their quality of life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
210
MD Anderson Cancer Center at Cooper
Camden, New Jersey, United States
MD Anderson Cancer Center at Cooper
Voorhees Township, New Jersey, United States
Change in Insomnia Severity Index
Change in Insomnia Severity Index (ISI) rating ratings in cancer survivors receiving CBT vs. MBSR interventions.
Time frame: Baseline to 6 weeks and 6 weeks to 12 weeks
Change in Brief Fatigue Inventory (BFI)
Change in Fatigue rating using the BFI in cancer survivors receiving CBT vs. MBSR interventions.
Time frame: Baseline to 6 weeks and 6 weeks to 12 weeks
Change in Depression, Anxiety and Stress Scale 21 (DASS21)
Change in Depression and Anxiety rating using the DASS21 in cancer survivors receiving CBT vs. MBSR interventions
Time frame: Baseline to 6 weeks and 6 weeks to 12 weeks
Number of patients who respond to CBT vs MBSR based on Ethnicity
Variations in efficacy outcomes based on ethnicity
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.